CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics
1. 10x Genomics collaborates on PERIBLOOD trial for blood disorder diagnostics. 2. Study includes over 1,500 participants across global sites over three years. 3. Trial uses single cell RNA sequencing as a non-invasive diagnostic method. 4. Success in the trial may reshape blood disorder diagnostics and treatment. 5. Advancements in genomics could enhance patient outcomes with less invasive procedures.